Atomoxetine Dosing and Titration for Adult Obese Females
For an adult obese female with ADHD, start atomoxetine at 40 mg daily for 7 days, then increase to 80 mg daily (the recommended target dose), with a maximum of 100 mg daily if needed after 2-4 weeks at target dose. 1
Initial Dosing Strategy
- Starting dose: 40 mg once daily in the morning 1
- Titration schedule: After 7 days, increase to 80 mg daily 1
- Administration: Can be given as a single morning dose OR divided into morning and late afternoon/early evening doses 1
The FDA label clearly establishes that atomoxetine should be started at 40 mg/day with rapid escalation to the target dose of 80 mg/day within the first week 1. This is critical because real-world data shows that only 45% of adult patients actually reach the recommended 80 mg dose, which is associated with significantly shorter treatment duration and suboptimal outcomes 2.
Target and Maximum Dosing
- Target dose: 80 mg daily 1
- Maximum dose: 100 mg daily 1
- Weight-based maximum: Not applicable for adults - dosing is fixed, not weight-based 1
Unlike pediatric dosing (which uses 1.2-1.8 mg/kg/day), adult atomoxetine dosing is not weight-based 1. The fact that your patient is obese does not change the dosing algorithm - the same 40-80-100 mg progression applies regardless of body weight.
Critical Timing Considerations
Wait 4-6 weeks at the 80 mg target dose before judging efficacy or increasing to 100 mg 3. This is a common pitfall - clinicians often increase doses too quickly or abandon treatment before allowing adequate time at therapeutic levels. The medication requires sustained exposure at target dose to demonstrate full effect 3.
Patients who reach 80 mg by Day 30 have significantly longer treatment duration (159 days vs 66 days for those who don't reach target) 2. Early, aggressive titration to target dose is associated with better long-term adherence and outcomes.
Dosing Schedule Options
You have two evidence-based options 1:
- Once-daily morning dosing: Simpler, proven effective in clinical trials
- Divided dosing (morning + late afternoon/early evening): May provide more consistent coverage throughout the day
Both regimens are equally valid. Choose based on patient preference and daily schedule demands.
Special Considerations for Obesity
While obesity does not alter the dosing algorithm for ADHD treatment, note that atomoxetine at 100 mg daily has shown modest weight loss effects (-3.6 kg over 12 weeks) in obese women 4. This is a potential beneficial side effect rather than a reason to modify dosing. The medication is not approved for weight management, but this effect may be clinically relevant for your patient.
Common Pitfalls to Avoid
- Underdosing: The average real-world adult dose is only ~60 mg/day, well below the 80 mg target 3. This leads to treatment failure and discontinuation.
- Premature dose escalation: Don't increase to 100 mg before allowing 4-6 weeks at 80 mg 3
- Premature discontinuation: Ensure adequate trial duration at target dose before declaring treatment failure
- Assuming weight-based dosing: Adults use fixed dosing, not mg/kg calculations 1
Monitoring
Most common adverse effects are nausea, headache, and appetite changes 5. These are generally mild and transient. Monitor blood pressure and heart rate at baseline and after reaching target dose 1.